ImmunoHorizon Issues Research Articles in February 2022 Edition
February 17, 2022
February 17, 2022
ROCKVILLE, Maryland, Feb. 17 -- ImmunoHorizon, a peer-reviewed journal from the American Association of Immunologists that says it focuses on immunology, published research articles on the following topics in its February 2022 edition:
* IL-17 Receptor Signaling through IL-17A or IL-17F Is Sufficient to Maintain Innate Response and Control of Helicobacter pylori Immunopathogenesis
* Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and . . .
* IL-17 Receptor Signaling through IL-17A or IL-17F Is Sufficient to Maintain Innate Response and Control of Helicobacter pylori Immunopathogenesis
* Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and . . .